Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2020-08-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$417.6m reported value +13.1% vs Q1 2020
16positions
89.1%in top 10
9 new 0 added 4 reduced 9 sold out vs Q1 2020

Holdings, Q2 2020

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CONSTELLATION PHARMCETICLS I COM CNST CNST 4,016,873 $120.7m28.90% 28.90% UnchangedShares held: Q4 2019 —, Q1 2020 4.0m, Q2 2020 4.0m
2 TRILLIUM THERAPEUTICS INC COM NEW TR TR 6,790,000 $54.9m13.15% 13.15% UnchangedShares held: Q4 2019 —, Q1 2020 6.8m, Q2 2020 6.8m
3 ALTIMMUNE INC COM NEW ALT ALT 4,500,000 $48.2m11.54% 11.54% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 4.5m
4 RELMADA THERAPEUTICS INC COM RLMD RLMD 668,440 $29.9m7.16% 7.16% ReducedShares held: Q4 2019 —, Q1 2020 842.8k, Q2 2020 668.4k -174.4k -174,374 -20.7%
5 SURFACE ONCOLOGY INC COM SURF SURF 3,877,895 $25.4m6.09% 6.09% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 3.9m
6 KEROS THERAPEUTICS INC COM KROS KROS 672,306 $25.2m6.04% 6.04% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 672.3k
7 VAXART INC COM NEW VXRT VXRT 2,765,000 $24.5m5.86% 5.86% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 2.8m
8 MYOVANT SCIENCES LTD COM MYOV MYOV 845,000 $17.4m4.17% 4.17% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 845.0k
9 MARINUS PHARMACEUTICALS INC COM MRNS MRNS 5,726,540 $14.5m3.48% 3.48% ReducedShares held: Q4 2019 —, Q1 2020 6.5m, Q2 2020 5.7m -776.3k -776,300 -11.9%
10 INARI MED INC COM NARI NARI 235,000 $11.4m2.73% 2.73% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 235.0k
11 KURA ONCOLOGY INC COM KURA KURA 575,000 $9.4m2.24% 2.24% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 575.0k
12 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 625,710 $9.3m2.22% 2.22% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 625.7k
13 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 1,057,827 $8.5m2.05% 2.05% UnchangedShares held: Q4 2019 —, Q1 2020 1.1m, Q2 2020 1.1m
14 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 781,940 $7.8m1.87% 1.87% NewShares held: Q4 2019 —, Q1 2020 0, Q2 2020 781.9k
15 89BIO INC COM ETNB ETNB 291,140 $5.8m1.39% 1.39% ReducedShares held: Q4 2019 —, Q1 2020 952.2k, Q2 2020 291.1k -661.1k -661,060 -69.4%
16 SIERRA ONCOLOGY INC COM NEW COM NEW 378,888 $4.6m1.10% 1.10% ReducedShares held: Q4 2019 —, Q1 2020 491.0k, Q2 2020 378.9k -112.1k -112,129 -22.8%

Sold out since Q1 2020

SecurityTickerShares held beforeValue then
AXSOME THERAPEUTICS INC AXSM AXSM 810,000 $47.7m810.0k shares
INOVIO PHARMACEUTICALS INC 2,900,000 $21.6m2.9m shares
10X GENOMICS INC TXG TXG 300,000 $18.7m300.0k shares
MERSANA THERAPEUTICS INC 2,623,903 $15.3m2.6m shares
VERASTEM INC 3,720,930 $9.8m3.7m shares
ADVERUM BIOTECHNOLOGIES INC 994,381 $9.7m994.4k shares
IVERIC BIO INC OPHT OPHT 2,586,537 $8.9m2.6m shares
SPERO THERAPEUTICS INC SPRO SPRO 474,015 $3.8m474.0k shares
PROTAGONIST THERAPEUTICS INC PTGX PTGX 113,140 $799.0k113.1k shares